Shana Wheeler
Family · Birmingham, ALNPI 1275050387
Payments from drug & device makers
Across 276 payments — averaging $19.13 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Gilead$1K
- Viiv Healthcare Company$1K
- AbbVie$762
- Novo Nordisk$403
- Merck$306
- Bausch Health US, LLC$192
- plus $1K from 24 others
What the payments were for
- Food & beverage$5,280100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Gilead | 50 | $1,164 |
| Viiv Healthcare Company | 56 | $1,029 |
| AbbVie | 52 | $762 |
| Novo Nordisk | 22 | $403 |
| Merck | 11 | $306 |
| Bausch Health US, LLC | 11 | $192 |
| AstraZeneca | 5 | $183 |
| Amarin Pharma, Inc. | 10 | $179 |
| Lilly USA, LLC | 9 | $158 |
| GSK | 6 | $115 |
| Bayer | 6 | $111 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 6 | $100 |
| Dexcom, Inc. | 5 | $99 |
| Johnson & Johnson | 4 | $58 |
| Tolmar, Inc. | 3 | $55 |
| Paratek Pharmaceuticals, Inc. | 3 | $44 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $43 |
| Vanda Pharmaceuticals Inc. | 1 | $39 |
| Boehringer Ingelheim | 2 | $31 |
| Pfizer | 2 | $30 |
| Axsome Therapeutics, Inc. | 1 | $22 |
| Theratechnologies Inc. | 1 | $21 |
| Seqirus USA Inc | 1 | $19 |
| Supernus Pharmaceuticals, Inc. | 1 | $18 |
| Antares Pharma, Inc. | 1 | $18 |
| Verity Pharmaceuticals Inc. | 1 | $17 |
| Esperion Therapeutics, Inc. | 1 | $17 |
| Hologic Sales And Service, LLC | 1 | $17 |
| Exact Sciences | 1 | $15 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- AIRSUPRA$122
How this compares
$5,280 in reported general payments places this provider in the 90th percentile of 3,415 family providers in Alabama.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| DescovyEmtricitabine/Tenofov Alafenam | 14 | $29,399 |
| OzempicSemaglutide | 31 | $28,754 |
| MounjaroTirzepatide | 11 | $11,370 |
| JanuviaSitagliptin Phosphate | 20 | $10,506 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 12 | $7,093 |
| VascepaIcosapent Ethyl | 12 | $3,981 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 17 | $966 |
| Levothyroxine Sodium | 30 | $423 |
| Rosuvastatin Calcium | 22 | $349 |
| Atorvastatin Calcium | 33 | $325 |
| Carvedilol | 29 | $293 |
| Losartan Potassium | 26 | $265 |
| Amlodipine Besylate | 47 | $250 |
| Metformin Hcl | 15 | $240 |
| Fluticasone Propionate | 23 | $193 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| GileadDescovy | $1,164 | $29,39914 claims |
| Novo NordiskOzempic | $403 | $28,75431 claims |
| Lilly USA, LLCMounjaro | $158 | $11,37011 claims |
| MerckJanuvia | $306 | $10,50620 claims |
| GSKTrelegy Ellipta | $115 | $7,09312 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 3,415 family providers in Alabama.
Other family in Birmingham
- Kellyn McMahonBirmingham$39K
- Rachel MesserBirmingham$22K
- Juyong JacksonBirmingham$21K
- Abigail McCroryBirmingham$19K
- Danielle BlackardBirmingham$19K
- Leanne PeoplesBirmingham$17K
- Brandie WeidmanBirmingham$13K
- Alison PetersonBirmingham$13K
- Justin WilsonCullman$1.1M
- Leigh Ann ChildressHuntsville$240K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.